Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole

Life Sciences

Volumn 110, Issue 1, 2014, Pages 35-43

  Ahmed, Tarek A ^a,b   El Say, Khalid M ^b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Al Azhar University   (Egypt)

Author keywords

Alginate; chitosan; nanoemulsion; nanoparticles; transdermal patches

Indexed keywords

ALGINIC ACID; CELLULOSE DERIVATIVE; CHITOSAN; NANOPARTICLE; OIL; RABEPRAZOLE; SURFACTANT; GLUCURONIC ACID; HEXURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CERVICAL SPINE DISLOCATION; COATED PARTICLE; CROSS LINKING; DRUG FORMULATION; ENTERIC COATED TABLET; EX VIVO STUDY; EXPERIMENTAL DESIGN; IN VITRO STUDY; KINETICS; MALE; MOUSE; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PLACKETT BURMAN DESIGN; SCANNING ELECTRON MICROSCOPE; SKIN PERMEABILITY; SUSTAINED DRUG RELEASE; TRANSDERMAL PATCH; WATER IN OIL NANOEMULSION; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; EMULSION; INTRADERMAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; METABOLISM; METHODOLOGY; PERMEABILITY; RAT; SCANNING ELECTROCHEMICAL MICROSCOPY; SKIN; SKIN ABSORPTION; WISTAR RAT;

ALGINATE; CHITOSAN; NANOEMULSION; NANOPARTICLES; TRANSDERMAL PATCHES;

ADMINISTRATION, CUTANEOUS; ALGINATES; ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EMULSIONS; GLUCURONIC ACID; HEXURONIC ACIDS; KINETICS; MALE; MICROSCOPY, ELECTROCHEMICAL, SCANNING; NANOPARTICLES; PARTICLE SIZE; PERMEABILITY; RABEPRAZOLE; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; SURFACE-ACTIVE AGENTS; TRANSDERMAL PATCH;

EID: 84907029228     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.06.019     Document Type: Article

References (41)

1. F.O.M.S. Abreu, C. Bianchini, M.M.C. Forte, and T.B.L. Kist Influence of the composition and preparation method on the morphology and swelling behavior of alginate-chitosan hydrogels Carbohydr Polym 74 2008 283 289
2. F.O.M.S. Abreu, M.M.C. Forte, T.B.L. Kist, and L.P. Honaiser Effect of the preparation method on the drug loading of alginate-chitosan microspheres eXPRESS Polym Lett 4 8 2010 456 464
3. K. Adachi, T. Katsube, A. Kawamura, T. Takashima, M. Yuki, and K. Amano CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole Aliment Pharmacol Ther 14 2000 1259 1266
4. T. Ando, T. Ishikawa, S. Kokura, Y. Naito, N. Yoshida, and T. Yoshikawa Endoscopic analysis of gastric ulcer after one week's treatment with omeprazole and rabeprazole in relation to CYP2C19 genotype Dig Dis Sci 53 2008 933 937
5. E. Azizi, A. Namazi, I. Haririan, S. Fouladdel, M.R. Khoshayand, and P.Y. Shotorbani Release profile and stability evaluation of optimized chitosan/alginate nanoparticles as EGFR antisense vector Int J Nanomedicine 5 2010 455 461
6. J. Berger, M. Reist, J.M. Mayer, O. Felt, N.A. Peppas, and R. Gurny Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications Eur J Pharm Biopharm 57 1 2004 19 34
7. P. Costa, and J.M. Sousa Lobo Modeling and comparison of dissolution profiles Eur J Pharm Sci 13 2 2001 123 133
8. P.J. Cox, K.A. Khan, D.L. Munday, and J. Sujja-areevath Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics Int J Pharm 193 1999 73 84
9. S.J. Desai, P. Singh, A.P. Simonelli, and W. Higuchi Investigation of factors influencing release of solid drug dispersed in inert matrices III. Quantitative studies involving the polyethylene plastic matrix J Pharm Sci 55 11 1966 1230 1234
10. Y. El-Malah, and S. Nazzal Hydrophilic matrices: application of Placktt-Burman screening design to model the effect of POLYOX-carbopol blends on drug release Int J Pharm 309 2006 163 170
11. P.V. Finotelli, D. Da Silva, M. Sola-Penna, A.M. Rossi, M. Farina, and L.R. Andrade Microcapsules of alginate/chitosan containing magnetic nanoparticles for controlled release of insulin Colloids Surf B Biointerfaces 81 1 2010 206 211
12. T. Gazori, M.R. Khoshayand, E. Azizi, P. Yazdizade, A. Nomani, and I. Haririan Evaluation of alginate/chitosan nanoparticles as antisense delivery vector: formulation, optimization and in vitro characterization Carbohydr Polym 77 2009 599 606
13. M. George, and T.E. Abraham Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review J Control Release 114 1 2006 1 14
14. R.S. Harland, A. Gazzaniga, M.E. Sangalli, and P. Colombo Drug/polymer matrix swelling and dissolution Pharm Res 5 1988 488 494
15. T. Higuchi Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices J Pharm Sci 52 12 1963 1145 1149
16. H.M. Ibrahim, T.A. Ahmed, A.E. Lila, A.M. Samy, A.A. Kaseem, and M.T. Nutan Mucoadhesive controlled release microcapsules of indomethacin: optimization and stability study J Microencapsul 27 5 2010 377 386
17. P. Izquierdo, J. Esquena, Th.F. Tadros, C. Dederen, M.J. Garcia, and N. Azemar Formation and stability of nano-emulsions prepared using the phase inversion temperature method Langmuir 18 2002 26 30
18. P. Izquierdo, J. Esquena, Th.F. Tadros, J.C. Dederen, J. Feng, and M.J. Garcia-Celma Phase behavior and nano-emulsion formation by the phase inversion temperature method Langmuir 20 2004 6594 6598
19. R. Jadhav, K. More, D. Khandekar, R. Yamgar, and S. Sawant An efficient synthesis of rabeprazole sodium Asian J Pharm Res 1 1 2011 13 16
20. M.H. Kafshgari, M. Khorram, M. Khodadoost, and S. Khavari Reinforcement of chitosan nanoparticles obtained by an ionic cross-linking process IRAN POLYM J 20 5 2011 445 456
21. M.A. Khan, S.V. Sastry, S.R. Vaithiyalingam, V. Agarwal, S. Nazzal, and I.K. Reddy Captopril gastrointestinal therapeutic system coated with cellulose acetate pseudolatex: evaluation of main effects of several formulation variables Int J Pharm 193 2000 147 156
22. R.W. Korsmeyer, R. Gurny, E. Doelker, P. Buri, and N. Peppas Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air J Pharm Sci 72 10 1983 1189 1191
23. G.A. Lewis, D. Mathieu, and R. Phan-Tan-Luu Pharmaceutical Experimental Design 1999 Marcel Dekker New York
24. S. Mutalik, N. Udupa, S. Kumar, S. Agarwal, G. Subramanian, and A.K. Ranjith Glipizide matrix transdermal systems for diabetes mellitus: preparation, in vitro and preclinical studies Life Sci 79 16 2006 1568 1577
25. Y. Ozsoy, S. Güngör, and E. Cevher Vehicle effects on in vitro release of tiaprofenic acid from different topical formulations Farmaco 59 7 2004 563 566
26. R.P. Patel, G. Patel, and A. Baria Formulation and evaluation of transdermal patch of aceclofenac Int J Drug Deliv 1 2009 41 51
27. M. Porras, C. Solans, C. Gonzalez, A. Martínez, A. Guinart, and J.M. Gutiérrez Studies of formation of W/O nano-emulsions Colloids Surf A Physicochem Eng Asp 249 2004 115 118
28. M. Porras, A. MartInez, and C. Solans Ceramic particles obtained using W/O nano-emulsions as reaction media Colloids Surf A Physicochem Eng Asp 270-271 2005 189 194
29. P. Prabhakara, M. Koland, K. Vijaynarayana, N.M. Harish, G. Shankar, and M.G. Ahmed Preparation and evaluation of transdermal patches of papaverine hydrochloride Int J Res Pharm Sci 1 3 2010 259 266
30. A.J. Ribeiro, C. Silva, D. Ferreira, and F. Veiga Chitosan reinforced alginate microspheres obtained through the emulsification/internal gelation technique Eur J Pharm Sci 25 1 2005 31 40
31. P. Ritger, and N. Peppas A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Release 5 1987 37 42
32. T. Saitoh, Y. Fukushima, H. Otsuka, J. Hirakawa, H. Mori, and T. Asano Effects of rabeprazole, lansoprazole and omeprazole on intragastric pH in CYP2C19 extensive metabolizers Aliment Pharmacol Ther 16 2002 1811 1817
33. B. Sarmento, D.C. Ferreira, L. Jorgensen, and M. van de Weert Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles Eur J Pharm Biopharm 65 1 2007 10 17
34. D.A. Sclar, T.A. Tartaglione, and M.J. Fine Overview of issues related to medical compliance with implications for the outpatient management of infectious diseases Infect Agents Dis 3 1994 266 273
35. Tadros ThF P. Becher, Encyclopedia of Emulsion Technology vol. 1 1983 Marcel Deckker New York 129 285
36. A. Tripathi, B.S. Joshi, and J. Joshi Polymorphism in rabeprazole sodium RASAYAN J Chem 3 4 2010 736 744
37. H.K. Vaddi, P.C. Ho, and S.Y. Chan Terpenes in propylene glycol as skin-penetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry J Pharm Sci 91 7 2002 1639 1651
38. J. Wagner Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules J Pharm Sci 58 1969 1253 1257
39. L. Wang, X. Li, G. Zhang, J. Dong, and J. Eastoe Oil-in-water nanoemulsions for pesticide formulations J Colloid Interface Sci 314 1 2007 230 235
40. H.O. Yamano, H.O. Matsushita, and S. Yanagiwara Plasma concentration of rabeprazole after 8-week administration in gastroesophageal reflux disease patients and intragastric pH elevation J Gastroenterol Hepatol 23 2008 534 540
41. Y. Zhang, W. Wei, P. Lv, L. Wang, and G. Ma Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin Eur J Pharm Biopharm 77 1 2011 11 19